Accelerate Diagnostics

Accelerate Diagnostics, Inc. (Nasdaq:AXDX), is an in vitro diagnostics company focused on developing and commercializing innovative systems for the rapid identification and antimicrobial susceptibility testing of infectious pathogens. The company's revolutionary ID/AST platform utilizes a proprietary process with both genomic and phenotypic detection technologies that significantly decreases time to result while achieving high sensitivity and specificity. In addition to the Accelerate ID/AST System development pipeline, the company also owns and licenses its proprietary OptiChem™ surface coatings technology, which has numerous applications for binding in bio-analytical systems, such as microarrays.
Type
Public
HQ
Tucson, US
Founded
2004
Employees
113 (est)+55%
Accelerate Diagnostics was founded in 2004 and is headquartered in Tucson, US

Accelerate Diagnostics Locations

Tucson, US
Castelldefels, ES

Accelerate Diagnostics Metrics

Accelerate Diagnostics Summary

Market capitalization

$1.19 B

Closing share price

$23.3
Accelerate Diagnostics's latest market capitalization is $1.19 B.

Accelerate Diagnostics Market Value History

Accelerate Diagnostics Online Presence

Accelerate Diagnostics News

Accelerate Diagnostics Company Life

You may also be interested in